Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE GRENOT : revenue, balance sheet and financial ratios

PHARMACIE GRENOT is a French company founded 29 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ROUEN (76000), this company of category PME shows in 2024 a net income negative of -12 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE GRENOT (SIREN 409025525)
Indicator 2024 2018 2017 2016
Revenue N/C N/C N/C N/C
Net income -12 188 € -364 € -182 € -220 €
EBITDA N/C -98 € -182 € -220 €
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2024, PHARMACIE GRENOT records a net loss of 12 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-12 188 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 20%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 71%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

20.097%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

70.72%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

55.1%

Solvency indicators evolution
PHARMACIE GRENOT

Sector positioning

Debt ratio
20.1 2024
2017
2018
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good

In 2024, the debt ratio of PHARMACIE GRENOT (20.10) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
70.72% 2024
2017
2018
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent

In 2024, the financial autonomy of PHARMACIE GRENOT (70.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
-637.33 years 2018
2017
2018
Q1: 1.86 years
Med: 5.41 years
Q3: 9.79 years
Excellent -9 pts over 2 years

In 2018, the repayment capacity of PHARMACIE GRENOT (-637.33) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 410.75. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

410.748

Liquidity indicators evolution
PHARMACIE GRENOT

Sector positioning

Liquidity ratio
410.75 2024
2017
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent +73 pts over 2 years

In 2024, the liquidity ratio of PHARMACIE GRENOT (410.75) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
-271.43x 2018
2017
2018
Q1: 1.93x
Med: 6.3x
Q3: 12.69x
Watch

In 2018, the interest coverage of PHARMACIE GRENOT (-271.4x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Positioning of PHARMACIE GRENOT in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE GRENOT with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE GRENOT

What is the revenue of PHARMACIE GRENOT ?

The revenue of PHARMACIE GRENOT is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE GRENOT profitable?

PHARMACIE GRENOT recorded a net loss in 2024.

Where is the headquarters of PHARMACIE GRENOT ?

The headquarters of PHARMACIE GRENOT is located in ROUEN (76000), in the department Seine-Maritime.

Where to find the tax return of PHARMACIE GRENOT ?

The tax return of PHARMACIE GRENOT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE GRENOT operate?

PHARMACIE GRENOT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.